Ardent Health Reports Second Quarter 2026 Results
Ardent Health reported Q2 revenue of $1.62 billion, down 1.4% year-over-year, with net income falling 77% to $17 million or $0.12 per share. The decline was primarily driven by the lapping of a two-quarter benefit from the New Mexico state directed payment program and lower surgical volumes. Despite the earnings pressure, operating cash flow increased 67% to $197 million, and the company repurchased 1.4 million shares for $13 million during the quarter.
Key figures
- Eps
- 0.12
- Revenue
- 1622245000
- Guidance
- FY2026 Revenue $6.4B-$6.7B, Adjusted EBITDA $485M-$535M (Reaffirmed)
- Revenue Yoy
- -1.4%
- Net income
- 17000000
- Adjusted ebitda
- 115000000
- Repurchase cost
- 13000000
- Net leverage ratio
- 0.8x
- Repurchased shares
- 1400000
- Operating cash flow
- 197000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.